Choosing which in-hospital laboratory tests to target for intervention: a scoping review

被引:4
作者
Podolsky, Eyal [1 ,2 ]
Hudek, Natasha [2 ]
McCudden, Christopher [2 ,3 ,4 ]
Presseau, Justin [1 ,2 ]
Yanikomeroglu, Sezgi [2 ]
Brouwers, Melissa [1 ]
Brehaut, Jamie C. C. [1 ,2 ]
机构
[1] Univ Ottawa, Sch Epidemiol & Publ Hlth, 451 Smyth Rd, Ottawa, ON, Canada
[2] Ottawa Hosp, Ottawa Hosp Res Inst, Ctr Practice Changing Res, Clin Epidemiol Program, Gen Campus,501 Smyth Rd,Box 201B, Ottawa, ON K1H 8L6, Canada
[3] Ottawa Hosp, Dept Pathol & Lab Med, Div Biochem, Ottawa, ON, Canada
[4] Eastern Ontario Reg Lab Assoc, Ottawa, ON, Canada
基金
加拿大健康研究院;
关键词
laboratory testing; low-value; scoping review; INFLAMMATORY-BOWEL-DISEASE; COLORECTAL-CANCER; PRACTICE GUIDELINES; TUMOR-MARKERS; CLINICAL MICROBIOLOGY; AMERICAN ASSOCIATION; RHEUMATIC-DISEASES; PRACTICE PARAMETER; THYROID-FUNCTION; EUROPEAN GROUP;
D O I
10.1515/cclm-2022-0910
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
IntroductionSome laboratory testing practices may be of low value, leading to wasted resources and potential patient harm. Our scoping review investigated factors and processes that developers report using to inform decisions about what tests to target for practice improvement.MethodsWe searched Medline on May 30th, 2019 and June 28th, 2021 and included guidelines, recommendation statements, or empirical studies related to test ordering practices. Studies were included if they were conducted in a tertiary care setting, reported making a choice about a specific test requiring intervention, and reported at least one factor informing that choice. We extracted descriptive details, tests chosen, processes used to make the choice, and factors guiding test choice.ResultsFrom 114 eligible studies, we identified 30 factors related to test choice including clinical value, cost, prevalence of test, quality of test, and actionability of test results. We identified nine different processes used to inform decisions regarding where to spend intervention resources.ConclusionsIntervention developers face difficult choices when deciding where to put scarce resources intended to improve test utilization. Factors and processes identified here can be used to inform a framework to help intervention developers make choices relevant to improving testing practices.
引用
收藏
页码:388 / 401
页数:14
相关论文
共 143 条
[1]   Update: Interim Guidance for the Diagnosis, Evaluation, and Management of Infants with Possible Congenital Zika Virus Infection - United States, October 2017 [J].
Adebanjo, Tolulope ;
Godfred-Cato, Shana ;
Viens, Laura ;
Fischer, Marc ;
Staples, J. Erin ;
Kuhnert-Tallman, Wendi ;
Walke, Henry ;
Oduyebo, Titilope ;
Polen, Kara ;
Peacock, Georgina ;
Meaney-Delman, Dana ;
Honein, Margaret A. ;
Rasmussen, Sonja A. ;
Moore, Cynthia A. .
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2017, 66 (41) :1089-1099
[2]   International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies [J].
Agmon-Levin, Nancy ;
Damoiseaux, Jan ;
Kallenberg, Cees ;
Sack, Ulrich ;
Witte, Torsten ;
Herold, Manfred ;
Bossuyt, Xavier ;
Musset, Lucille ;
Cervera, Ricard ;
Plaza-Lopez, Aresio ;
Dias, Carlos ;
Sousa, Maria Jose ;
Radice, Antonella ;
Eriksson, Catharina ;
Hultgren, Olof ;
Viander, Markku ;
Khamashta, Munther ;
Regenass, Stephan ;
Coelho Andrade, Luis Eduardo ;
Wiik, Allan ;
Tincani, Angela ;
Ronnelid, Johan ;
Bloch, Donald B. ;
Fritzler, Marvin J. ;
Chan, Edward K. L. ;
Garcia-De la Torre, I. ;
Konstantinov, Konstantin N. ;
Lahita, Robert ;
Wilson, Merlin ;
Vainio, Olli ;
Fabien, Nicole ;
Sinico, Renato Alberto ;
Meroni, Pierluigi ;
Shoenfeld, Yehuda .
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (01) :17-23
[3]  
Allison JE, 1998, ALIMENT PHARM THERAP, V12, P1
[4]   Expert Recommendations on Frequency of Utilization of Common Laboratory Tests in Medical Inpatients: a Canadian Consensus Study [J].
Ambasta, Anshula ;
Pancic, Stefana ;
Wong, Brian M. ;
Lee, Todd ;
McCaughey, Deirdre ;
Ma, Irene W. Y. .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2019, 34 (12) :2786-2795
[5]  
Amicosante M, 2010, NEW MICROBIOL, V33, P93
[6]  
[Anonymous], 2016, MMWR-MORBID MORTAL W, V65, P474, DOI [10.15585/mmwr.mm6518e1, 10.15585/mmwr.mm6518e1]
[7]  
[Anonymous], 2016, PRESS PEER REV EL SE
[8]  
[Anonymous], COV SYST REV SOTW
[9]  
Arksey H., 2005, INT J SOC RES METHOD, V8, P19, DOI [DOI 10.1080/1364557032000119616, 10.1080/1364557032000119616]
[10]  
ASGE guidelines for clinical application, 1999, GASTROINTEST ENDOSC, V50, P906, DOI DOI 10.1016/S0016-5107(99)70192-6